The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab beyond first progression in cases of HER2-positive advanced gastric or gastro-esophageal junction cancer: Initial results from KSCC1105, a trastuzumab observational cohort study.
 
Akitaka Makiyama
No Relationships to Disclose
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Tomomi Kashiwada
No Relationships to Disclose
 
Ikuo Takahashi
No Relationships to Disclose
 
Yasunori Emi
Speakers' Bureau - Chugai Pharma
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Kazuharu Yamamoto
No Relationships to Disclose
 
Hiroshi Ishikawa
No Relationships to Disclose
 
Yuji Negoro
No Relationships to Disclose
 
Eiji Oki
Consulting or Advisory Role - Chugai Pharma
Speakers' Bureau - Chugai Pharma
 
Hiroshi Saeki
Employment - Chugai Pharma (I)
 
Yoshihiro Kakeji
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical
 
Hideo Baba
Speakers' Bureau - Chugai Pharma
Research Funding - Chugai Pharma (Inst)
 
Yoshihiko Maehara
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma